NCT00747487View on ClinicalTrials.gov

Study to Assess Efficacy,Safety and Tolerability of Idebenone in the Treatment of Leber's Hereditary Optic Neuropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Leber's Hereditary Optic Neuropathy
Interventions
DRUG

Idebenone

Idebenone 900 mg/day

DRUG

Placebo

Placebo

Trial Locations (3)

81377

Klinikum der Universität München - Grosshadern, Neurologische Klinik und Poliklinik, Munich

H2L 4M1

Unité de recherche clinique Ophtalmologie- Hopital Notre-Dame, Montreal

NE1 4LP

Clinical Research Facility, 4th Floor Leazes Wing, Royal Victoria Infirmary, Newcastle upon Tyne

Sponsors
All Listed Sponsors
lead

Santhera Pharmaceuticals

INDUSTRY

NCT00747487 - Study to Assess Efficacy,Safety and Tolerability of Idebenone in the Treatment of Leber's Hereditary Optic Neuropathy | Biotech Hunter | Biotech Hunter